Splash Beverage Group

SBEV

SPLASH announces significant actions designed to strengthen the Company's financial position and advance its previously announced NYSE compliance plan.

FORT LAUDERDALE, Fla., July 09, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash," "Splash Beverage" or the "Company") today announced that NYSE American has accepted the Company's plan to regain compliance with the Exchange's continued listing standards and has granted the Company a compliance period through January 29, 2027.

$SBEV announces licensing agreement with Argent BioPharma for CannEpil®, a proprietary, cannabinoid-based therapeutic for the treatment of epilepsy (DRE)

FORT LAUDERDALE, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) today announced the completion of a CDN$300,000 strategic investment in Avicanna Inc. (TSX: AVCN), a commercial-stage cannabinoid-based biopharmaceutical company focused on clinical research, patient care, and developing pharmaceutical products.

FORT LAUDERDALE, Fla., June 03, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company"), today provided a corporate update regarding its NYSE American compliance process, ongoing strategic transaction initiatives, and certain required disclosures.

FORT LAUDERDALE, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group (NYSE American: SBEV) (“Splash” or the “Company”) today announced the appointment of Brady Cobb as Interim Chief Executive Officer, effective immediately.

FORT LAUDERDALE, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), today announced that on April 29, 2026, it received a notice from NYSE Regulation (the “NYSE”) indicating that the Company is not currently in compliance with the NYSE's continued listing standards related to minimum shareholders' equity. In accordance with NYSE requirements, the Company is required to submit a plan by May 29, 2026, outlining the actions it has taken or will take to regain compliance. If the plan is accepted, the Company may be granted a cure period extending through January 29, 2027 to restore compliance with the continued listing standards.

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants — ticker symbol SBEV-WT — to purchase common stock of Splash Beverage Group, Inc. (the “Company”) from the NYSE American, since the Company's warrants are no longer suitable for listing pursuant to Section 1001 of the NYSE American Company Guide (the “Company Guide”) due to the low trading price of such w.

NEW YORK--(BUSINESS WIRE)--NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Splash Beverage Group, Inc. (the “Company”) from the Exchange. Symbol Description SBEV Common Stock, par value $0.001 per share SBEV-WT Warrants to purchase shares of common stock NYSE Regulation has determined that the Company is no longer suitable for listing pur.

FORT LAUDERDALE, FL / ACCESSWIRE / December 12, 2024 / Splash Beverage Group, Inc. (NYSE American:SBEV), an innovator in the beverage industry, proudly announces another 2024 retail expansion win. Total Wine & More, America's Wine Superstore and the country's largest independent retailer of fine wine, has authorized Pulpoloco Sangria across multiple states.